NOVS-100

N/A

Report date: 2023/08/02 17:31:33
NME

Base Information

Drug NameNOVS-100
Drug Alias NameNOVS-100
ClassificationSmall molecules
Mechanisms of ActionFatty acid binding protein 5 inhibitorsFatty acid-binding protein, adipocyte inhibitors
TargetsFatty acid binding protein 5Fatty acid-binding protein, adipocyte
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelloram Inc
China Registration ClassN/A

Develop Information

Active CompaniesCelloram Inc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A